Morgan Stanley's decision to maintain an Equal-Weight rating on Planet Labs indicates a neutral outlook for the stock. However, the lowered price target from $6 to $5.5 may cause some investors to reevaluate their positions, but the overall impact on the stock price is expected to be neutral in the short term.